Find a Tender
complete
Official procurement procedure
National Microbiology Framework - Lot 3: Manufacturing, Product Development and Commercialisation
Medical equipments
pharmaceuticals and personal care products
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Public Health England: "National Microbiology Framework - Lot 3: Manufacturing, Product Development and Commercialisation". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Public Health England | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Public Health England
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Public Health England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
89Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 4 active published awards; 4 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityPublic Health England | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published24 Apr 2021, 22:54 BST | Last source update24 Apr 2021, 22:54 BST | Recurring procurementNot published |
ClassificationMedical equipments, pharmaceuticals and personal care products | ||
Delivery area UK | ||
OCIDocds-h6vhtk-02a9e3 | ||
What is being bought
Lot 3 is for the manufacturing, product development and commercialisation of diagnostic and/or therapeutic products for the purpose of research, experimentation, study, development or to establish commercial viability or to recover research and development costs.
Please note that this Award Notice is for Lot 3, however the Framework Agreement encompasses the following four lots:
- Lot 1: Diagnostic Goods and Services
- Lot 2: Research and Development Goods and Services
- Lot 3: Manufacturing, Product Development and Commercialisation
- Lot 4: Clinical Laboratory Diagnostic Testing Services
What changed
From the official release history
- Status changed to complete
24 Apr 2021, 22:54 BST - Official notice release published
24 Apr 2021, 22:54 BST - Buyer information updated
24 Apr 2021, 22:54 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedThe Framework Agreement relates to the supply of diagnostics Goods for the qualitative / quantitative examination of specimens / samples and the development or manufacturing of assays / kits / medication and related Services. It also relates to the supply of diagnostics Services for the qualitative / quantitative examination of specimens / samples or the development or manufacturing of assays / kits / medication. The framework also covers Clinical Laboratory Diagnostic Testing Services. The term of the framework will be for an initial 2 years with options to extend by up to a further 2 years. Additional information: The value attributed to each Lot is an approximate estimate only. As indicated in Section VI.3. of this Notice, the actual values will be to such level as those purchasing under the Framework Agreement consider necessary to provide suitable requirements.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
24 Apr 2021, 22:54 BST - Award active
Not published · Not published - Contract active
Signed 9 Apr 2021, 00:00 BST · £2,500,000,000
Commercial outcome and competition
Awards AusDiagnostics UK Limited, Bio-Techne Ltd, Europlaz Technologies Limited, Immensa Health Clinic Ltd, Life Technologies Limited, Qiagen Ltd, Randox Laboratories Ltd, Thermo Fisher Diagnostics Ltd, Yourgene Health UK Limited Not published · Not published · active |
Contracts Manufacturing, Product Development and Commercialisation £2,500,000,000 · signed 9 Apr 2021, 00:00 BST · active |
Bid statistics bids: 17 (lot 1) |
Buyer and organisations in this procedure
Public Health England
Contracting authority GB-FTS-12759Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published